PARIS — A single cardiac troponin measurement by high-sensitivity cardiac troponin I (hs-cTnI) assay can safely and effectively rule out myocardial infarction (MI) at presentation, results from more ...
Incorporating high-sensitivity cardiac troponin (hs-cTn) testing into the traditional HEART pathway may improve detection of acute MI in patients presenting to the emergency department (ED) with chest ...
The diagnostics advisory committee considered evidence on high-sensitivity troponin tests for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI) from several sources. Full ...
PARIS — An early rule-out pathway using high-sensitivity cardiac troponin I was able to safely and effectively identify MI in patients with suspected ACS, according to data from the HiSTORIC trial ...
Implementing the high-sensitivity troponin (hsTn)-based HEART pathway in US emergency departments (EDs) improves acute myocardial infarction (AMI) diagnosis. This multicenter pre-post cohort study was ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among patients with STEMI, 1 in 4 had troponin ...
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k ...
PARIS, France (UPDATED)—Using a single measurement of cardiac troponin I with a high-sensitivity assay to triage patients presenting with suspected ACS promises to clear out emergency departments (EDs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback